Vaidya Sane Ayurved Laboratories Share Price

Vaidya Sane Ayurved Laboratories Investment Rating

• Master Rating:

• Vaidya Sane Ayurved Laboratories has an operating revenue of Rs. 264.71 Cr. on a trailing 12-month basis. An annual revenue growth of 44% is outstanding, Pre-tax margin of 6% is okay, ROE of 9% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 47 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 70 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.